Michaela Koehm, MD (she/her/hers)

University Hospital Frankfurt
Frankfurt, Germany

Rheumatologist

Presentation(s):

• 1440: Removal of Methotrexate in Patients with Active Psoriatic Arthritis with Newly Induced Ustekinumab Treatment Leads to a Delayed Response in DAPSA and DAS28 Within the First 16 Weeks

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.